The Latest Cardiac and Vascular News
A Breakthrough in Dialysis Access ST. LOUIS, Jan. 13, 2026 /PRNewswire/ — Amplifi Vascular, Inc., has been granted Breakthrough Device Designation and Category B assignment from the Centers for Medicare & Medicaid Services (CMS) for the Amplifi Vein Dilation System. This significant…
Company announces positive first-in-human study results, the close of a $6.9 million Series A financing, and FDA approval of its Investigational Device Exemption. ST. LOUIS, Oct. 9, 2025 /PRNewswire/ — Amplifi Vascular, developer of the first-of-its-kind Vein Dilation System designed to…
PRAIRIE VILLAGE, Kan., Nov. 30, 2021 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that full results from its first-in-human (FIH) clinical study of the Amplifi™ Vein Dilation System were presented at the 2021 VEITH Symposium by Surendra Shenoy, MD-PhD, […]
First-of-its-kind technology demonstrates exceptional initial results in hemodialysis patients PRAIRIE VILLAGE, Kan., Oct. 7, 2021 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that preliminary clinical results from its first-in-human study of the Amplifi™ Vein Dilation System were presented […]
Novel vein dilation system aims to improve vascular access for hemodialysis patients Prairie Village, KS – July 14, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today it has completed enrollment in its first-in-human study evaluating the […]
